299 related articles for article (PubMed ID: 30087005)
1. Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook.
Scarnati MS; Halikere A; Pang ZP
Alcohol; 2019 Feb; 74():83-93. PubMed ID: 30087005
[TBL] [Abstract][Full Text] [Related]
2. Application of induced pluripotent stem cells to understand neurobiological basis of bipolar disorder and schizophrenia.
Liu YN; Lu SY; Yao J
Psychiatry Clin Neurosci; 2017 Sep; 71(9):579-599. PubMed ID: 28393474
[TBL] [Abstract][Full Text] [Related]
3. Ethanol-mediated activation of the NLRP3 inflammasome in iPS cells and iPS cells-derived neural progenitor cells.
De Filippis L; Halikere A; McGowan H; Moore JC; Tischfield JA; Hart RP; Pang ZP
Mol Brain; 2016 May; 9(1):51. PubMed ID: 27160314
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of iPS-derived neural cells to examine biologic effects of alcohol on human neurons in vitro.
Lieberman R; Levine ES; Kranzler HR; Abreu C; Covault J
Alcohol Clin Exp Res; 2012 Oct; 36(10):1678-87. PubMed ID: 22486492
[TBL] [Abstract][Full Text] [Related]
5. Modeling human neurological disorders with induced pluripotent stem cells.
Imaizumi Y; Okano H
J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the biology of bipolar disorder using induced pluripotent stem-derived neurons.
Miller ND; Kelsoe JR
Bipolar Disord; 2017 Nov; 19(7):544-551. PubMed ID: 29116664
[TBL] [Abstract][Full Text] [Related]
7. Highly Expandable Human iPS Cell-Derived Neural Progenitor Cells (NPC) and Neurons for Central Nervous System Disease Modeling and High-Throughput Screening.
Cheng C; Fass DM; Folz-Donahue K; MacDonald ME; Haggarty SJ
Curr Protoc Hum Genet; 2017 Jan; 92():21.8.1-21.8.21. PubMed ID: 28075486
[TBL] [Abstract][Full Text] [Related]
8. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
9. Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.
Barnes J; Salas F; Mokhtari R; Dolstra H; Pedrosa E; Lachman HM
Mol Autism; 2018; 9():44. PubMed ID: 30147856
[TBL] [Abstract][Full Text] [Related]
10. Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities.
Madison JM; Zhou F; Nigam A; Hussain A; Barker DD; Nehme R; van der Ven K; Hsu J; Wolf P; Fleishman M; O'Dushlaine C; Rose S; Chambert K; Lau FH; Ahfeldt T; Rueckert EH; Sheridan SD; Fass DM; Nemesh J; Mullen TE; Daheron L; McCarroll S; Sklar P; Perlis RH; Haggarty SJ
Mol Psychiatry; 2015 Jun; 20(6):703-17. PubMed ID: 25733313
[TBL] [Abstract][Full Text] [Related]
11. Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells.
van Hugte E; Nadif Kasri N
Adv Exp Med Biol; 2019; 1192():297-312. PubMed ID: 31705501
[TBL] [Abstract][Full Text] [Related]
12. Neonatal mouse cortical but not isogenic human astrocyte feeder layers enhance the functional maturation of induced pluripotent stem cell-derived neurons in culture.
Lischka FW; Efthymiou A; Zhou Q; Nieves MD; McCormack NM; Wilkerson MD; Sukumar G; Dalgard CL; Doughty ML
Glia; 2018 Apr; 66(4):725-748. PubMed ID: 29230877
[TBL] [Abstract][Full Text] [Related]
13. Genetics of Alcohol Use Disorder: A Role for Induced Pluripotent Stem Cells?
Prytkova I; Goate A; Hart RP; Slesinger PA
Alcohol Clin Exp Res; 2018 Sep; 42(9):1572-1590. PubMed ID: 29897633
[TBL] [Abstract][Full Text] [Related]
14. Examining the effects of alcohol on GABA
Lieberman R; Kranzler HR; Levine ES; Covault J
Alcohol; 2018 Feb; 66():45-53. PubMed ID: 29156239
[TBL] [Abstract][Full Text] [Related]
15. Pluripotent stem cells in neuropsychiatric disorders.
Soliman MA; Aboharb F; Zeltner N; Studer L
Mol Psychiatry; 2017 Sep; 22(9):1241-1249. PubMed ID: 28322279
[TBL] [Abstract][Full Text] [Related]
16. Neural Stem Cells and Human Induced Pluripotent Stem Cells to Model Rare CNS Diseases.
De Filippis L; Zalfa C; Ferrari D
CNS Neurol Disord Drug Targets; 2017; 16(8):915-926. PubMed ID: 28641519
[TBL] [Abstract][Full Text] [Related]
17. Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder.
Watmuff B; Liu B; Karmacharya R
Pharmacogenomics; 2017 Apr; 18(5):471-479. PubMed ID: 28346060
[TBL] [Abstract][Full Text] [Related]
18. Disease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.
Watmuff B; Berkovitch SS; Huang JH; Iaconelli J; Toffel S; Karmacharya R
Mol Cell Neurosci; 2016 Jun; 73():96-103. PubMed ID: 26777134
[TBL] [Abstract][Full Text] [Related]
19. 5. Collaborative Study on the Genetics of Alcoholism: Functional genomics.
Gameiro-Ros I; Popova D; Prytkova I; Pang ZP; Liu Y; Dick D; Bucholz KK; Agrawal A; Porjesz B; Goate AM; Xuei X; Kamarajan C; ; Tischfield JA; Edenberg HJ; Slesinger PA; Hart RP
Genes Brain Behav; 2023 Oct; 22(5):e12855. PubMed ID: 37533187
[TBL] [Abstract][Full Text] [Related]
20. Current concepts of ethanol dependence.
Littleton J; Little H
Addiction; 1994 Nov; 89(11):1397-412. PubMed ID: 7841849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
